Download PDF
CC BY 4.0 · World J Nucl Med 2024; 23(02): 073-078
DOI: 10.1055/s-0044-1778712
Original Article

Status and Development of Nuclear Medicine Over One Decade in Beijing

Fei Luo 
1   Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People's Republic of China
2   Department of Nuclear Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
,
Jianhua Geng
2   Department of Nuclear Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
,
Shengzu Chen
2   Department of Nuclear Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objective Our objective was to investigate the basic information of the personnel and facilities of nuclear medicine in Beijing.

Methods This survey was performed by the Beijing Quality Control Center in 2018. The investigation included personnel, equipment, and clinical applications, and data were then compared with previous surveys. The paper questionnaires were used for the survey, which required information about the personnel, devices, and clinical applications.

Results About 38 nuclear medicine departments in Beijing were involved in the survey. The number of nuclear medicine staff was 531 in 2018, showing an increase of 58.7% over the past decade. Positron emission tomography/computed tomography (PET/CT), single-photon emission computed tomography (SPECT), and single-photon emission computed tomography/computed tomography (SPECT/CT) represented the main nuclear medicine facilities, and the total number of surveyed departments was 18, 24, and 34, respectively. The quality control results showed significant improvement from the 2005 levels. The total number of scintigraphy procedures was estimated at 199,607 (153,185 SPECT and 46,422 PET/CT). The estimated annual number of scintigraphy images was 8.9 per 1,000 population for SPECT and 2.7 per 1,000 population for PET/CT during 2018. The most frequent radioiodine-targeted therapy was 131I-targeted therapy for hyperthyroidism in 2018.

Conclusion Nuclear medicine has experienced rapid growth in the past 10 years in Beijing, either in personnel, equipment, and scintigraphy. Future efforts will focus on the use of new isotopes in the diagnosis, implementing quality strategy, and enhancing training.

Keywords

nuclear medicine practice - positron emission tomography - single-photon emission computed tomography - quality control - nuclear medicine personnel - nuclear medicine imaging

Author's Contributions

J.H.G. designed the research; J.H.G., S.Z.C., and F.L. collected and analyzed data; F.L. and J.H.G. wrote the paper; all authors provided patients data and approved the paper.




Publication History

Article published online:
11 April 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Zuckier LS. Hybrid imaging in planar scintigraphy: new implementations and historical precedents. Semin Nucl Med 2012; 42 (01) 62-72
    CrossrefPubMedGoogle Scholar
  • 2 Zaidi H, Mawlawi O, Orton CG. Point/counterpoint. Simultaneous PET/MR will replace PET/CT as the molecular multimodality imaging platform of choice. Med Phys 2007; 34 (05) 1525-1528
    CrossrefPubMedGoogle Scholar
  • 3 Hongwei S, Jianhua G, Shengzu C. Status of nuclear medicine in Beijing: insights from the Beijing Quality Control Centre Survey 2005-2006. Nucl Med Commun 2008; 29 (03) 298-302
    CrossrefPubMedGoogle Scholar
  • 4 Hongwei S, Jianhua G, Shengzu C. Nuclear medicine scans in Beijing: insights from the Beijing Quality Control Centre Survey 2005-2006. Nucl Med Commun 2007; 28 (08) 661-666
    CrossrefPubMedGoogle Scholar
  • 5 Goksel F, Peksoy I, Koc O, Gultekin M, Ozgul N, Sencan I. Planning of nuclear medicine in Turkey: current status and future perspectives. Asian Pac J Cancer Prev 2012; 13 (05) 1989-1994
    CrossrefPubMedGoogle Scholar
  • 6 Pachocki KA, Sackiewicz-Slaby A. Determining the current status and potential of nuclear medicine in Poland. Rocz Panstw Zakl Hig 2013; 64 (03) 243-250
    PubMedGoogle Scholar
  • 7 Lee DS, Lee YS, Lee JS, Suh MS. Promotion of nuclear medicine-related sciences in developing countries. Nucl Med Mol Imaging 2019; 53 (02) 73-82
    CrossrefPubMedGoogle Scholar
  • 8 Cheng JL, Dibble EH, Baird GL, Gordon LL, Hyun H. Diversity, equity, and inclusion in academic nuclear medicine: national survey of nuclear medicine residency program directors. J Nucl Med 2021; 62 (09) 1207-1213
    CrossrefPubMedGoogle Scholar
  • 9 Gordon L, Lapi SE, Anderson C, Schwarz SW. SNMMI Committee on Women in Nuclear Medicine. Working together to advance women in nuclear medicine. J Nucl Med 2016; 57 (09) 14N
    PubMedGoogle Scholar
  • 10 Lasnon C, Girault G, Lebtahi R, Ansquer C, Lequesne J, Quak E. Female authors in nuclear medicine journals: a survey from 2014 to 2020. J Nucl Med 2022; 63 (07) 995-1000
    CrossrefPubMedGoogle Scholar
  • 11 Kinuya S, Kuwabara Y, Inoue K. et al. Nuclear medicine practice in Japan: a report of the seventh nationwide survey in 2012. Ann Nucl Med 2014; 28 (10) 1032-1038
    CrossrefPubMedGoogle Scholar
  • 12 Koizumi K, Masaki H, Matsuda H. et al; Japanese Society of Nuclear Medicine, Optimization Committee for Pediatric Nuclear Medicine Studies. Japanese consensus guidelines for pediatric nuclear medicine. Part 1: pediatric radiopharmaceutical administered doses (JSNM pediatric dosage card). Part 2: technical considerations for pediatric nuclear medicine imaging procedures. Ann Nucl Med 2014; 28 (05) 498-503
    CrossrefPubMedGoogle Scholar
  • 13 Kim SY, Xydias T, Peters AA. et al. Radiologists and nuclear medicine physicians are looking forward to a cross-curricular training. Eur Radiol 2019; 29 (09) 4803-4811
    CrossrefPubMedGoogle Scholar
  • 14 Graham MM, Metter DF. Evolution of nuclear medicine training: past, present, and future. J Nucl Med 2007; 48 (02) 257-268
    PubMedGoogle Scholar
  • 15 Bielsa IR. Pediatric nuclear medicine and its development as a specialty. Semin Nucl Med 2017; 47 (02) 102-109
    CrossrefPubMedGoogle Scholar
  • 16 Bires AM, Mason DL, Gilmore D, Pietrzyk C. Gap analysis survey: an aid in transitioning to standardized curricula for nuclear medicine technology. J Nucl Med Technol 2012; 40 (03) 178-182
    CrossrefPubMedGoogle Scholar
  • 17 Gelfand MJ, Clements C, MacLean JR. Nuclear medicine procedures in children: special considerations. Semin Nucl Med 2017; 47 (02) 110-117
    CrossrefPubMedGoogle Scholar
  • 18 Sammer MBK, Sher AC, States LJ, Trout AT, Seghers VJ. Current trends in pediatric nuclear medicine: a Society for Pediatric Radiology membership survey. Pediatr Radiol 2020; 50 (08) 1139-1147
    CrossrefPubMedGoogle Scholar
  • 19 Mann A, Farrell MB, Williams J, Basso D. Nuclear medicine technologists’ perception and current assessment of quality: A Society of Nuclear Medicine and Molecular Imaging Technologist Section Survey. J Nucl Med Technol 2017; 45 (02) 67-74
    CrossrefPubMedGoogle Scholar